Our Board
The Board provides oversight, strategic direction and strong governance for Myeloma Australia. With broad expertise across clinical practice, research, finance and community leadership, they ensure our programs, services and advocacy efforts remain aligned with the needs of the myeloma community.
Jeff Browne is a senior commercial lawyer with deep expertise across corporate, media, sport and intellectual property law, and is the founder of a specialist commercial law firm. He has extensive experience advising major organisations on complex negotiations, contracts, governance structures and commercial strategy.
Jeff played a significant role in shaping the modern AFL commercial and governance model, including stadium development and league structures. He also brings senior executive and board‑level experience in media and entertainment, including leadership roles involving strategic, rights and content negotiations with Nine Entertainment. Known for his commercial, solutions‑focused approach, he balances legal risk with business outcomes and offers strong governance capability across national boards, sporting bodies and complex stakeholder environments.
Hamish George is a Chartered Accountant with deep experience in financial governance, audit, risk management and compliance. He brings senior executive‑level experience overseeing financial strategy, reporting, budgeting and capital management, with a strong focus on long‑term financial sustainability.
Hamish has expertise in cost control, forecasting and investment oversight, and is highly experienced in board reporting, audit committee engagement and regulatory frameworks. He has supported organisations through periods of growth, transformation and turnaround, applying disciplined financial leadership to complex environments. Hamish also brings critical capability in ensuring transparent and accountable stewardship of donor and grant funding.
Brian Rosengarten is a co‑founder of Myeloma Australia and brings deep institutional knowledge, strong mission alignment and a lifelong commitment to improving outcomes for people affected by myeloma. He was awarded the Medal of the Order of Australia (OAM) in recognition of his significant contribution to the community.
With a background in pharmacy, Brian offers a strong understanding of patient care pathways, medicines and the broader health system. He has extensive experience in patient advocacy and community leadership, particularly in raising awareness of blood cancers, and brings strong governance capability through his involvement in not‑for‑profit boards and advisory groups. Brian’s key strength is ensuring the patient and family voice, grounded in lived experience, informs strategy and decision‑making, supported by deep networks across healthcare professionals, patient groups and community stakeholders.
Professor Simon Harrison is a leading haematologist and Director of Immunotherapy at the Peter MacCallum Cancer Centre, and an internationally recognised expert in multiple myeloma and related blood cancers. He has extensive experience in clinical care, clinical trials, translational research and the development of new therapies, particularly immunotherapy‑based approaches.
Simon is an active contributor to global research collaborations and treatment guidelines and brings strong experience bridging clinical practice, research innovation and policy influence. As Chair of the Medical and Scientific Advisory Group, he provides the Board with cutting‑edge medical insight, clinical credibility and leadership in shaping evidence‑based strategy to improve patient outcomes.
Annree Wogan brings over 25 years experience across the pharmaceutical and biotechnology sectors, with deep expertise in Medical Affairs. Her background includes clinical trial design, execution and governance, regulatory engagement, and evidence generation to support patient access and treatment decision‑making.
Annree has extensive experience working with clinicians, regulators and global pharmaceutical organisations, and is highly skilled in translating complex clinical data into strategic and commercial insights. She brings a valuable perspective on how therapies progress from research and development through to real‑world access, supported by experience in market access, stakeholder engagement and health policy.
Adam Schwab is the co‑founder of Luxury Escapes, a high‑growth global travel platform, and brings strong entrepreneurial, commercial and digital capability to the Board. With qualifications in law and commerce, he combines legal, financial and strategic expertise with hands‑on experience scaling complex businesses.
Adam has a proven track record in marketing, customer acquisition, technology platforms and data‑driven growth, alongside experience in capital raising, investor relations and strategic partnerships. As an active public voice on business, innovation and policy, he contributes a contemporary, growth‑oriented mindset and digital perspective to support the organisation’s sustainability and impact.
Marlo McCarthy lives with myeloma, a reality that grounds her perspective in firsthand experience. She knows what diagnosis, treatment and ongoing care actually demand physically, emotionally and practically. That knowledge didn’t come from research or secondhand reports. It came from navigating the uncertainty of test results, the exhaustion of treatment and the lifelong process of adapting to a new normal. She brings that lived understanding to her work with Myeloma Australia and the broader community.
For Marlo, this work is deeply personal. It’s about making sure the person hearing their diagnosis for the first time has somewhere to turn. She pushes for better awareness because she knows too many people still face this disease feeling isolated. She speaks up for equity because a person’s background shouldn’t determine the quality of their care. At the core of all she does is a simple principle: patients should have a voice. She is dedicated to strengthening the myeloma community by helping ensure every person affected feels seen, heard and supported.
Nick Green brings a strong personal connection to the myeloma community through his family’s experience with the disease. When his wife, Taimi, was diagnosed, Nick gained firsthand insight into the complexities of treatment and the real impact on families. He saw up close how vital trusted information, compassionate care and sustained support are for those affected by myeloma.
A dual Olympic gold medallist and respected leader across sport, community and not-for-profit sectors, Nick is committed to improving outcomes for people living with myeloma. He is focused on strengthening community support, advancing research and ensuring patients and families have equitable access to care. His contribution is shaped by integrity, leadership and a strong belief in what people can achieve together.
Downloadable resources
Access our comprehensive guides and infosheets whenever you need them. Download PDFs to read on your device or save for later.
These resources cover everything from understanding your diagnosis to managing treatment, giving you reliable information you can refer back to anytime.
Order your own copy
Prefer a printed version? We can send our guides directly to your home at no cost. Having a physical copy on hand can make it easier to read, share with family, or take notes as you go.
Myeloma – a comprehensive guide
This guide is written for people who have been diagnosed with myeloma, their families, carers and friends.
Telephone Support Line
Talk directly with our specialist myeloma nurses who understand exactly what you’re going through.
Use our simple booking form below to schedule your personalised consultation at a time that works for you.
Get the expert guidance and emotional support you need, when you need it most.
Connect with us
Stay informed with the latest myeloma research, treatment updates, and support resources. We offer tailored newsletters for both patients and healthcare professionals with relevant information and community updates.
